These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2216528)

  • 1. [Blood level profile of valproate administration under therapeutic conditions in children].
    Meyer FP; Sauer I; Staemmler U; Walther H
    Padiatr Grenzgeb; 1990; 29(4):325-30. PubMed ID: 2216528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Certain aspects of interaction between sodium valproate and other anticonvulsant drugs in the therapy of epilepsy in children.
    Sobaniec W
    Mater Med Pol; 1992; 24(2):115-9. PubMed ID: 1307765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and pharmacokinetic observations on valproate: a 3 year follow-up study in 100 children with generalized epilepsy.
    Steinborn B; Galas-Zgorzalewicz B
    Funct Neurol; 1993; 8(6):415-22. PubMed ID: 8150320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium valproate: dose-plasma level relationships and interdose fluctuations.
    Vajda FJ; Mihaly GW; Miles JL; Morris PM; Bladin PF
    Clin Exp Neurol; 1978; 15():145-53. PubMed ID: 386306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy.
    Chou IJ; Lin KL; Wang HS; Wang CJ
    Acta Paediatr Taiwan; 2007; 48(6):317-22. PubMed ID: 18437965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of valproate therapy on thrombin generation determined by calibrated automated thrombography.
    Topf HG; Lischetzki G; Trollmann R; Rascher W; Rauh M
    Klin Padiatr; 2011 May; 223(3):165-8. PubMed ID: 21472635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of valproate in Mexican children with epilepsy.
    Correa T; Rodríguez I; Romano S
    Biopharm Drug Dispos; 2008 Dec; 29(9):511-20. PubMed ID: 19067436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose sodium valproate therapy for childhood refractory epilepsy.
    Amano R; Mizukawa M; Ohtsuka Y; Ohtahara S
    Jpn J Psychiatry Neurol; 1990 Jun; 44(2):343-4. PubMed ID: 2124287
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of serum concentrations of melatonin by carbamazepine and valproate.
    Gupta M; Kohli K; Gupta YK
    Indian J Physiol Pharmacol; 2006; 50(1):79-82. PubMed ID: 16850908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of age, body weight and dose on sodium valproate plasma concentrations in children with epilepsy].
    Jiang Z; Zhang J; Liao HM; Tang JW; Peng QL
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):325-8. PubMed ID: 18554460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma sodium valproate levels and clinical response in epilepsy.
    Anthony M; Hinterberger H; Lance JW
    Clin Exp Neurol; 1977; 14():208-15. PubMed ID: 358186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid in childhood epilepsy: anticonvulsive efficacy in relation to its plasma levels.
    Klotz U; Schweizer C
    Int J Clin Pharmacol Ther Toxicol; 1980 Oct; 18(10):461-5. PubMed ID: 6782028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of non-linear relationship between total and unbound serum concentrations of valproic acid in epileptic children.
    Ueshima S; Aiba T; Makita T; Nishihara S; Kitamura Y; Kurosaki Y; Kawasaki H; Sendo T; Ohtsuka Y; Gomita Y
    J Clin Pharm Ther; 2008 Feb; 33(1):31-8. PubMed ID: 18211614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of valproate and ethosuximide: antiepileptic and neurotoxic interaction.
    Bourgeois BF
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1128-32. PubMed ID: 3144596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Critical remarks about the monitoring of antiepileptic drug levels in pediatric age (author's transl)].
    Gaggero R; La Medica ; De Negri M
    Pediatr Med Chir; 1981; 3(2-3):151-8. PubMed ID: 6806780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid clearance in children with epilepsy.
    Sánchez-Alcaraz A; Quintana MB; López E; Rodríguez I
    J Clin Pharm Ther; 1998 Feb; 23(1):31-4. PubMed ID: 9756109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration.
    Dulac O; Alvarez JC
    Pharmacotherapy; 2005 Jan; 25(1):35-41. PubMed ID: 15767218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of carbamazepine and valproate on bone mineral density.
    Ecevit C; Aydoğan A; Kavakli T; Altinöz S
    Pediatr Neurol; 2004 Oct; 31(4):279-82. PubMed ID: 15464641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium valproate (Epilim) in the treatment of refractory epilepsy.
    Lines DR
    N Z Med J; 1978 Jan; 87(603):9-12. PubMed ID: 347342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.